Shilpa Medicare
Shilpa Medicare Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Europe and the United States. Founded in 1987, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals, particularly in oncology and other therapeutic areas. Shilpa Medicare is renowned for its innovative approach to drug formulation and delivery, offering a diverse portfolio of products that includes active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global healthcare providers. With a focus on research and development, Shilpa Medicare continues to advance its mission of improving patient outcomes worldwide.
DitchCarbon Score
How does Shilpa Medicare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shilpa Medicare's score of 26 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shilpa Medicare's reported carbon emissions
In 2023, Shilpa Medicare reported total carbon emissions of approximately 36,903,10 kg CO2e from Scope 1, 20,389,900 kg CO2e from Scope 2, and 710,410 kg CO2e from Scope 3. This represents a significant increase in emissions compared to 2022, where emissions were approximately 1,516,970 kg CO2e for Scope 1, 15,503,870 kg CO2e for Scope 2, and 877,770 kg CO2e for Scope 3. Shilpa Medicare has not set specific reduction targets or initiatives as part of their climate commitments, nor do they participate in initiatives such as the Science Based Targets initiative (SBTi). The company has not disclosed any climate pledges or reduction initiatives, indicating a potential area for future development in their sustainability strategy. The emissions data is not cascaded from any parent organization, and all figures are reported directly by Shilpa Medicare Limited. The company operates within the pharmaceutical industry, which is increasingly focusing on reducing carbon footprints and enhancing sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,516,970 | 0,000,000 |
| Scope 2 | 15,503,870 | 00,000,000 |
| Scope 3 | 877,770 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shilpa Medicare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
